Status: Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986368 in participants with Multiple Sclerosis Spasticity
Participants needed: 200
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: CelgeneUpdated: Jun 8, 2026Locations: 54
Eligibility criteria
Participants must have a multiple sclerosis (MS) diagnosis. [+3]
Participants must not have any concomitant disease or disorder that has symptoms... [+5]